MedTrace Logo

Efficiency of CogniPlat on Cognitive Functions in Older Adults

NCT07130591 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-26

No results posted yet for this study

Summary

Mild cognitive impairment is a common intermediate stage between normal aging and dementia, affecting memory and other cognitive domains in older adults. While pharmacologic treatments lack strong evidence, exercise, cognitive training, and game-based interventions have shown positive effects on cognitive functions. The Cogniplat gaming platform, designed to improve cognitive abilities through personalized, multidisciplinary game exercises, has not yet been clinically evaluated. The present study aims to assess the effectiveness of Cogniplat in enhancing cognitive functions in geriatric individuals.

Conditions

Interventions

OTHER

Cogniplat game platform

The Cogniplat gaming platform is designed to improve cognitive function in geriatric individuals, with or without mild cognitive impairment. Participants played the Cogniplat games face-to-face with a physiotherapist twice a week on non-consecutive days for 10 weeks, sessions lasting about 30-45 minutes. Scores from the platform were recorded to evaluate progress.

OTHER

Control group

Individuals in this group did not participate in any regular play program. Demographic data were recorded. For evaluation purposes, a single session of Cogniplat game platform was applied in the first interview and in the second interview 10 weeks later. Initial and final evaluations were recorded.

Sponsors & Collaborators

  • Izmir Democracy University

    lead OTHER

Principal Investigators

  • Betül Taspinar, Prof.Dr. · Izmir Democracy University

  • Ayşe Sezgi Kızılırmak Karataş, Pt.PhD · Izmir Democracy University

  • Nuri Üçler, Msc.Pt. · Ege University

  • Ebru Köse, Pt.PhD · Izmir Democracy University

  • Cansu Ozdemir, Msc.Pt · Izmir Democracy University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2023-05-15
Completion
2023-11-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07130591 on ClinicalTrials.gov